Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 2383752.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A retrospective study of 91 patients with malignant melanoma treated by lower limb isolated hyperthermic regional perfusion was performed. Objective response in patients with evaluable disease was 78 per cent. The role of perfusion as primary treatment of large melanomas of the foot is confirmed and recommended. Control of locoregional disease and limb salvage remains a valuable and attainable therapeutic goal using this technique.
Medical subject headings
- Chemotherapy, Cancer, Regional Perfusion
- Hyperthermia, Induced
- Leg
- Melanoma
- Melphalan